News

Intensive human agricultural activities have caused a significant increase in ammonia emissions to the atmosphere, which have led to serious environmental and public health problems. Now, scientists have developed a portable and solar-powered open-path ammonia analyzer to help accurate quantification towards control and mitigation strategies.

A team of researchers has developed a new way to tag tumor cells to figure out how they evolve and change over time to resist cancer treatments.

Researchers have discovered two distinct ways in which an enzyme called APOBEC3A is controlled. The enzyme is responsible for genetic changes resulting in numerous cancer types while protecting our cells against viral infection.

Novobiocin, an antibiotic developed in the 1950s, has been found to effectively target and kill cancer cells with abnormal BRCA1 or BRCA2 genes.

Scientists have repurposed the genetic modification technology CRISPR to identify antibodies in patient blood samples in a move that could inspire a new class of medical diagnostics in addition to a host of other applications.

Researchers recently reported that MRI could reduce overdiagnoses and thereby improve prostate cancer screening. Now, the same research group has published a study which shows that the addition of a novel blood test, the Stockholm3 test, can reduce the number of MRIs performed by a third while further preventing the detection of minor, low-risk tumours.

A tool created by scientists allows researchers, farmers, policymakers and other interested parties test different land management techniques to find out which ones and where could be most beneficial for bees.

Brain-computer interfaces (BCIs) are assistive devices that may one day help people with brain or spinal injuries to move or communicate. Researchers have taken a step toward a new concept for a future BCI system – one that employs a coordinated network of independent, wireless neural sensors, each about the size of a grain of salt, to record and stimulate brain activity.

In a study, short naps of 30 or 60 minutes did not show any measurable effects against sleep deprivation.

An investigator-initiated Phase 1 clinical trial evaluating the checkpoint inhibitor nivolumab in combination with tumor-infiltrating lymphocyte (TIL) therapy.